Nonseminomatous Germ Cell Tumor (NSGCT)
The most likely histologic diagnosis is nonseminomatous germ cell tumor (NSGCT), based on the markedly elevated AFP and LDH levels. 1, 2
Diagnostic Reasoning
Tumor Marker Interpretation
The markedly elevated alpha-fetoprotein (AFP) is the definitive discriminating marker that establishes this diagnosis:
- AFP is produced exclusively by nonseminomatous germ cell tumor cells and is never elevated in pure seminoma, making it 100% specific for distinguishing tumor type 2
- Any elevation of AFP above the normal range indicates the presence of nonseminomatous elements, even if histology appears to be "pure seminoma" 1, 2
- The National Comprehensive Cancer Network explicitly states that if AFP is positive, the patient must be managed as having nonseminoma 1
Supporting Clinical Features
Additional findings that support NSGCT diagnosis:
- Partially necrotic mass on ultrasound is more characteristic of aggressive nonseminomatous tumors, which tend to have areas of hemorrhage and necrosis 3
- Elevated LDH serves as an important prognostic factor and is commonly elevated in advanced disease 3
- The solid mass presentation is consistent with germ cell tumors in general 4
Why Other Options Are Incorrect
- Seminoma (not listed but implied): Pure seminomas are constantly AFP-negative; any AFP elevation rules out pure seminoma 2
- Leydig cell tumor (Option A): These sex cord-stromal tumors do not produce AFP or typically present with markedly elevated tumor markers 3
- Sertoli cell tumor (Option C): Another sex cord-stromal tumor that does not produce AFP 3
- Teratoma (Option D): While teratomas are a type of NSGCT, they typically do not produce AFP unless combined with yolk sac tumor elements; the term "nonseminomatous germ cell tumor" is the broader, more accurate diagnosis 3
- Testicular lymphoma (Option E): Does not produce AFP or present with elevated germ cell tumor markers 3
Critical Clinical Caveat
Minor AFP elevations (≤16 ng/mL) should be interpreted cautiously as they may represent false-positives or borderline elevations that don't necessarily indicate occult NSGCT 3, 5. However, the question states "markedly elevated" AFP, which definitively indicates nonseminomatous disease requiring treatment as NSGCT 1
Management Implications
This patient requires: